$115.0 Million
Harpoon Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$62.2 Million
Aptose Biosciences Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$76.3 Million
Neoleukin Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$69.1 Million
Otonomy, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$80.0 Million
NantKwest (acquired by ImmunityBio)
Confidentially Marketed Follow-On Offering
Left Bookrunner
$40.0 Million
Leap Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$86.5 Million
OrthoPediatrics Corp.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$346.8 Million
ChemoCentryx, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$50.0 Million
Menlo Therapeutics Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$111.0 Million
Evofem Biosciences, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Subscribe to Equity Capital Markets

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.